Oppenheimer analyst Kevin DeGeeter reiterated an Outperform rating and $75.00 price target on Fulgent Genetics (NASDAQ: FLGT) after the NYC ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE